Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
Masayuki Hiraki(Osaka Health Science University), Donald Küfe(Dana-Farber Cancer Institute)
Cited by 64
Related Papers
Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors
|Hybridoma|1984|580
Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179
|Journal of Biological Chemistry|2006|232
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
|The American Journal of Medicine|1992|225
Interaction between Protein Kinase C δ and the c-Abl Tyrosine Kinase in the Cellular Response to Oxidative Stress
|Journal of Biological Chemistry|2000|206